95 related articles for article (PubMed ID: 7039893)
1. Autoantibody against fibroblasts in renal transplant recipients: analysis by 51Cr-release assays.
Aprile M; Halloran P; Haddad G; Robinette M
Clin Exp Immunol; 1981 Dec; 46(3):565-74. PubMed ID: 7039893
[TBL] [Abstract][Full Text] [Related]
2. Donor-specific antibodies in renal allograft recipients. A reevaluation of the 51Cr-release assays comparing fibroblast and lymphoid target cells.
Halloran PF; Aprile M; Haddad G; Cunningham K; Robinette MA
Transplantation; 1984 Apr; 37(4):356-8. PubMed ID: 6369664
[TBL] [Abstract][Full Text] [Related]
3. IgM antibodies in renal transplantation.
McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
[TBL] [Abstract][Full Text] [Related]
4. Detection of antidonor antibody: advantages of fibroblast target cells.
Halloran PF; Aprile M; Haddad G; Robinette M
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():49-55. PubMed ID: 386320
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat.
Paul LC; Muralidharan J; Muzaffar SA; Manting EH; Valentin JF; de Heer E; Kashgarian M
Am J Pathol; 1998 May; 152(5):1209-23. PubMed ID: 9588890
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
7. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
8. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of autoantibody expression in allogeneic stem-cell recipients.
Moon JH; Lee SJ; Kim JG; Chae YS; Kim SN; Kang BW; Suh JS; Lee KS; Sohn SK
Transplantation; 2009 Jul; 88(2):242-50. PubMed ID: 19623021
[TBL] [Abstract][Full Text] [Related]
10. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
11. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
Bućin D; Johansson S; Lindberg LO
Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
[TBL] [Abstract][Full Text] [Related]
12. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
[TBL] [Abstract][Full Text] [Related]
13. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
[TBL] [Abstract][Full Text] [Related]
14. [Non-HL-A specific autoantibody against granulocytes, lymphocytes and thrombocytes in a patient with agranulocytosis due to pyrazolone].
von Felten A; Müller-Schoop J; Gmür J
Schweiz Med Wochenschr; 1975 Nov; 105(47):1598. PubMed ID: 1209232
[TBL] [Abstract][Full Text] [Related]
15. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
16. Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens.
de Heer E; Davidoff A; van der Wal A; van Geest M; Paul LC
Lab Invest; 1994 Apr; 70(4):494-502. PubMed ID: 8176888
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
Sumitran-Karuppan S; Möller E
Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
[TBL] [Abstract][Full Text] [Related]
18. Alloantibodies and the outcome of cadaver kidney allografts.
Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against mesangial cells in a rat model of chronic renal allograft rejection.
Joosten SA; van Ham V; Borrias MC; van Kooten C; Paul LC
Nephrol Dial Transplant; 2005 Apr; 20(4):692-8. PubMed ID: 15701669
[TBL] [Abstract][Full Text] [Related]
20. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.
Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD
Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
